RegMedNet is a community site that unites the diverse regenerative medicine community. Through partnership with our sister journal, Regenerative Medicine, we seek to educate and inspire to help this exciting field move forward at an even faster rate. 

On RegMedNet, you can find free educational webinars, expert opinion and insight, and exclusive peer-reviewed journal articles, as well as the latest news and advances. Every step in the regenerative medicine and cell therapy pipeline is covered on RegMedNet, from development, clinical trial and manufacture to regulation and commercialization. RegMedNet members have the opportunity to connect and collaborate with industry leaders and academic experts as well as publish their own articles without the wait. 

Why should you join?

First and foremost, joining the network and sharing your news and knowledge contributes towards the development of this ground-breaking and promising field. At a more personal level, this network also gives you the opportunity to connect with your peers and help gain knowledge and connections that may be useful to your work, whether it is research or regulation.

RegMedNet is largely based on content generated by the network’s users and is designed to provide experts with a platform to collaborate, showcase their work and share news and their perspectives on the field.

RegMedNet at a glance

  • FREE and FAST access to editor- and user-generated news, discussion and opinion on key topics
  • Share your own news and views in posts, videos and panels
  • Network with your peers
  • Exclusive free access to selected journal articles published by Future Science Group
  • Weekly newsletter keeping you up to date

Did you know?

By joining RegMedNet, you also get free access to our partner sites. Simply sign in with your RegMedNet username and password and gain access to:

RxNet provides current and exciting research and information on all aspects of the drug discovery pipeline, in partnership with their associated journals, Future Drug Discovery, Future Medicinal Chemistry, Pharmaceutical Patent Analyst and Therapeutic Delivery.


Access your free account>>

3DMedNet unites the diverse 3D printing in medicine community, covering 3D printed pharmaceuticals, prosthetics, implants, medical devices and bioprinted tissue via expert opinion and insight, and exclusive peer-reviewed journal articles, as well as the latest news and advances.


Access your free account>>

The Evidence Base™ covers the latest news, opinion and insight into the collection and application of real-world data to real-world problems, including real-world evidence, health economics, comparative effectiveness research, patient-centered decision making and much more.

Access your free account>>

Who is RegMedNet?

There are plenty of wonderful people working behind the scenes to help this network operate, but the core team is:

  • Freya Leask, Publisher (
    Freya is the person you should speak to if you have any questions about using the network. You can find more about Freya by reading her profile, and can find her posts here. If you have ideas on what you'd like to see on RegMedNet, contact her now. You can also find the results of our recent member survey here.
  • Adam Price-Evans, Managing Commissioning Editor (
    Adam is the Commissioning Editor for Regenerative Medicine, the journal whose following inspired us to make this network. If you have any interest in submitting to the journal, he is the man you need to speak to. You can check out his posts and biography here.
  • Dionne Murray, Business Development Manager (
    As a member of our business development team, Dionne is the primary contact for all things related to sponsorship and advertising. Please see the sponsorship page for more details, and send her an email if you wish to discuss commercial opportunities available on RegMedNet.

If you would like to know more about using RegMedNet please see the user guide or speak to the Community Manager.


The opinions expressed on RegMedNet are those of the author and do not necessarily reflect the views of RegMedNet, Future Medicine Ltd or any of its affiliates.